Skip to main content

Advertisement

SpringerLink
Log in

Reduced ocular surface disease index (OSDI) scores in patients with isotretinoin treatment

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

To evaluate the changes in ocular surface and functions of tear-film in patients treated with systemic isotretinoin, to assess diagnostic performance of ocular surface disease index (OSDI) test in the dry eye conditions in association with the use of isotretinoin, and to determine the correlation between all tear-film function tests, OSDI and the dose and duration of isotretinoin administration. One hundred and twenty eyes of 60 subjects treated with oral isotretinoin were enrolled. All patients underwent ophthalmic examination at the baseline and another examination during the course of treatment. Biomicroscopic ophthalmic examination of the meibomian glands, non-anesthetized Schirmer test, and tear film break-up time (BUT) were performed. Subjective ocular complaints were scored with an OSDI questionnaire. Average Schirmer scores were not significantly changed by isotretinoin treatment. There were significant differences in the average OSDI score, the average meibomian gland disease (MGD) grade and average BUT value of both eyes during the treatment compared with baseline values (p < 0.01). There was a statistically significant inverse correlation between MGD grade and BUT value. There was no significant correlation between BUT value, OSDI score, Schirmer score, MGD grade, the total and divided dose of isotretinoin and the duration of treatment. The follow-up time was 4.01 ± 1.3 months (range 1.5–6 months). Systemic isotretinoin treatment can cause alterations in the tear film and dry eye symptoms. The OSDI test can be used as a diagnostic test for patients receiving systemic isotretinoin treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Thielitz A, Krautheim A, Gollnick H (2006) Update in retinoid therapy of acne. Dermatol Ther 19(5):272–279

    Article  PubMed  Google Scholar 

  2. Fraunfelder FT, Fraunfelder FW, Edwards R (2001) Ocular side effects possibly associated with isotretinoin usage. Am J Ophthalmol 132(3):299–305

    Article  CAS  PubMed  Google Scholar 

  3. Knop E, Knop N, Millar T et al (2011) The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci 52:1938–1978

    Article  PubMed  PubMed Central  Google Scholar 

  4. Nelson JD, Shimazaki J, Benitez-del-Castillo JM et al (2011) The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci 52:1930–1937

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ding J, Kam WR, Dieckow J, Sullivan DA (2013) The influence of 13-cis retinoic acid on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci 54(6):4341–4350

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mathers WD, Shields WJ, Sachdev MS et al (1991) Meibomian gland morphology and tear osmolarity: changes with accutane therapy. Cornea 10:286–290

    Article  CAS  PubMed  Google Scholar 

  7. Layton A (2009) The use of isotretinoin in acne. Dermatoendocrinol 1:162–169

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Melnik BC (2011) Isotretinoin and FoxO1: a scientific hypothesis. Dermatoendocrinol 3:141–165

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Schiffman RM, Christianson MD, Jacobsen G et al (2000) Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118(5):615–621

    Article  CAS  PubMed  Google Scholar 

  10. Johnson ME, Murphy PJ (2007) Measurement of ocular surface irritation on a linear interval scale with the ocular comfort index. Invest Ophthalmol Vis Sci 48(10):4451–4458

    Article  PubMed  Google Scholar 

  11. Schiffman RM, Christianson MD, Jacobsen G et al (2000) Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118:615–621

    Article  CAS  PubMed  Google Scholar 

  12. Tomlinson A, Bron AJ, Korb DR et al (2011) The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci 52:2006–2049

    Article  PubMed  PubMed Central  Google Scholar 

  13. Lin PY, Cheng CY, Hsu WM (2005) Association between symptoms and signs of dry eye among an elderly Chinese population in Taiwan: the Shihpai eye study. Invest Ophthalmol Vis Sci 46(5):1593–1598

    Article  PubMed  Google Scholar 

  14. Lekhanont K, Rojanaporn D, Chuck RS, Vongthongsri A (2006) Prevalence of dry eye in Bangkok. Thail Cornea 25(10):1162–1167

    Article  Google Scholar 

  15. Shimazaki J, Sakata M, Tsubota K (1995) Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol 113(10):1266–1270

    Article  CAS  PubMed  Google Scholar 

  16. Cumurcu T, Sezer E, Kilic R, Bulut Y (2009) Comparison of dose-related ocular side effects during systemic isotretinoin administration. Eur J Ophthalmol 19:196–200

    PubMed  Google Scholar 

  17. Moy A, McNamara NA, Lin MC (2015) Effects of isotretinoin on meibomian glands. Optom Vis Sci 92(9):925–930

    Article  PubMed  Google Scholar 

  18. Karalezli A, Borazan M, Altinors DD et al (2009) Conjunctival impression cytology, ocular surface and tear film changes in patients treated with systemic isotretinoin. Cornea 28(1):46–50

    Article  PubMed  Google Scholar 

  19. Egger SF, Huber-Spitzy V, Bohler K et al (1995) Ocular side effects associated with 13-cis-retinoic acid therapy for acne vulgaris: clinical features, alterations of tearfilm and conjunctival flora. Acta Ophthalmol Scand 73:355–357

    Article  CAS  PubMed  Google Scholar 

  20. Yildirim Y, Olcucu O, Agca A et al (2014) Evaluation of corneal topography and biomechanical parameters after use of systemic isotretinoin in acne vulgaris. J Ophthalmol 2014:701361

    Article  PubMed  PubMed Central  Google Scholar 

  21. Ensink BW, van Voorst Vader PC (1983) Ophthalmological side-effects of 13-cis-retinoid therapy. Br J Dermatol 108:627

    Article  CAS  PubMed  Google Scholar 

  22. Bozkurt B, Irkec MT, Atakan N et al (2012) Lacrimal function and ocular complications in patients treated with systemic isotretinoin. Eur J Ophthalmol 12(3):173–176

    Google Scholar 

  23. Fraunfelder FT, LaBraico JM, Meyer SM (1985) Adverse ocular reactions possibly associated with isotretinoin. Am J Ophthalmol 100:534–537

    Article  CAS  PubMed  Google Scholar 

  24. Hull PR, Demkiw-Bartel C (2000) Isotretinoin use in acne: prospective evaluation of adverse events. J Cutan Med Surg 4:66–70

    CAS  PubMed  Google Scholar 

  25. McLane J (2001) Analysis of common side effects of isotretinoin. J Am Acad Dermatol 45:188–194

    Article  Google Scholar 

  26. Schein OD, Tielsch JM, Munoz B et al (1997) Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology 104:1395–1401

    Article  CAS  PubMed  Google Scholar 

  27. Nichols KK, Nichols JJ, Mitchell GL (2004) The lack of association between signs and symptoms in patients with dry eye disease. Cornea 23(8):762–770

    Article  PubMed  Google Scholar 

Download references

Funding

The author(s) have no financial interest in any materials discussed in this article.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Faculty of Medicine, Hitit University, Corum Egitim ve Arastirma Hastanesi, Gazi Caddesi, 19200, Corum, Turkey

    Cagatay Caglar & Mustafa Durmus

  2. Department of Dermatology, Faculty of Medicine, Hitit University, Corum, Turkey

    Engin Senel & Emine Sabancilar

Authors
  1. Cagatay Caglar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Engin Senel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emine Sabancilar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mustafa Durmus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cagatay Caglar.

Ethics declarations

Conflict of interest

None of the authors have any proprietary interests or conflicts of interest related to this submission.

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

The patient’s parents have consented to the submission of the case report to the journal.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Caglar, C., Senel, E., Sabancilar, E. et al. Reduced ocular surface disease index (OSDI) scores in patients with isotretinoin treatment. Int Ophthalmol 37, 197–202 (2017). https://doi.org/10.1007/s10792-016-0263-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-016-0263-y

Keywords

Search

Navigation